MUMBAI, India, April 6, 2011 /PRNewswire/ -- SIRO Clinpharm, a leading Contract Research Organization (CRO) based out of India and Western and Central Eastern Europe, today announced the start of their operations in Malaysia thus expanding reach in the Asian continent.
Earlier in 2010, SIRO had announced strategic alliances with CROs in South Korea and Taiwan. "Malaysia is a highly developed and fast growing clinical trials destination and we are extremely proud to be one of the first India headquartered CROs to announce its operations," said Rajendra Talele, Vice President Clinical Operations, Asia. "Our first phase of service offerings will encompass clinical monitoring and project management activities."
"Besides advantages common to other Asian countries, what attracted us to Malaysia was a robust regulatory framework with compliant timelines, strong Government commitment towards clinical research and modern medical facilities," said Ajit Nair PhD, President Asia Business for SIRO.
"SIRO began India operations back in 1996 and that makes us one of India's most experienced CROs," said Chetan Tamhankar PhD, Chief Executive Officer of SIRO. "This expansion in Asia gives us an opportunity to immediately offer an additional geography to conduct clinical trials to our existing as well as potential clients. From a futuristic expansion perspective, we are in the process of evaluating Philippines and Thailand among other Asian countries for clinical operations."
SIRO Clinpharm is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. The company has offices in India, USA, Israel and in Europe in Germany, Czech Republic, Greece, Estonia, Romania, Spain and France.
For more information please visit - www.siroclinpharm.com
SOURCE SIRO Clinpharm